US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 7.840
  • -0.240-2.97%
Close Apr 24 15:59 ET
  • 7.650
  • -0.190-2.42%
Post 20:01 ET
522.15MMarket Cap-6.64P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics (FULC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2,608.07%-60.07M
-0.22%-16.8M
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
Net income from continuing operations
-669.97%-74.88M
-22.73%-20.33M
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
Depreciation and amortization
-12.74%1.39M
-5.96%347K
-6.23%346K
-8.51%344K
-26.30%353K
-26.66%1.59M
-27.36%369K
-30.51%369K
-33.69%376K
-15.37%479K
Change In working capital
192.04%3.91M
124.16%506K
657.32%2.29M
1,497.92%1.34M
86.47%-223K
7.91%-4.25M
-103.10%-2.09M
73.92%-410K
-112.31%-96K
40.93%-1.65M
-Change in receivables
234.45%2.1M
--0
--0
141.96%979K
108.01%1.12M
-406.17%-1.56M
3,527.91%1.56M
-1,840.79%-1.32M
-318.85%-2.33M
313.08%537K
-Change in prepaid assets
219.56%1.63M
121.26%44K
101.82%44K
-162.20%-288K
128.14%1.83M
-27.33%-1.37M
66.72%-207K
-250.29%-2.42M
-39.40%463K
253.83%803K
-Change in payables and accrued expense
155.35%1.45M
135.54%1.19M
52.25%2.43M
-57.05%831K
-6.24%-3M
-56.44%-2.63M
-3,727.17%-3.34M
369.48%1.6M
107.17%1.94M
-33.63%-2.82M
-Change in other current assets
-126.39%-528K
-901.52%-529K
-99.84%3K
-100.00%-2K
--0
2,028.72%2M
414.29%66K
38,160.00%1.91M
-102.78%-1K
-68.92%23K
-Change in other working capital
-6.14%-743K
-10.80%-195K
-12.07%-195K
-11.25%-178K
7.89%-175K
57.55%-700K
66.35%-176K
52.72%-174K
59.70%-160K
47.37%-190K
Cash from discontinued investing activities
Operating cash flow
-2,608.07%-60.07M
-0.22%-16.8M
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
Investing cash flow
Cash flow from continuing investing activities
-4.69%30.72M
-146.42%-1.05M
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
Net PPE purchase and sale
-12.95%-314K
31.17%-159K
-373.68%-90K
---65K
--0
45.28%-278K
-200.00%-231K
70.77%-19K
--0
83.63%-28K
Net investment purchase and sale
-4.54%31.03M
-135.73%-890K
328.06%18.7M
211.91%14M
-102.04%-777K
189.84%32.51M
-86.48%2.49M
-77.11%4.37M
-162.32%-12.51M
140.69%38.16M
Cash from discontinued investing activities
Investing cash flow
-4.69%30.72M
-146.42%-1.05M
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
Financing cash flow
Cash flow from continuing financing activities
6,042.28%168.67M
202,673.49%168.3M
-89.92%64K
-20.16%301K
0
-97.68%2.75M
-71.08%83K
635K
165.49%377K
-98.60%1.65M
Net common stock issuance
--164.5M
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
51.75%4.17M
4,480.72%3.8M
-89.92%64K
-20.16%301K
--0
253.41%2.75M
-71.08%83K
--635K
165.49%377K
374.43%1.65M
Cash from discontinued financing activities
Financing cash flow
6,042.28%168.67M
202,673.49%168.3M
-89.92%64K
-20.16%301K
--0
-97.68%2.75M
-71.08%83K
--635K
165.49%377K
-98.60%1.65M
Net cash flow
Beginning cash position
122.90%59.41M
-34.61%48.28M
-50.19%43.79M
5.42%43.38M
122.90%59.41M
-26.35%26.66M
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
Current changes in cash
325.30%139.32M
1,143.52%150.46M
131.84%4.49M
-99.11%414K
-210.62%-16.03M
443.56%32.76M
-219.19%-14.42M
-262.51%-14.09M
6,189.58%46.77M
4,082.14%14.5M
End cash Position
234.50%198.73M
234.50%198.73M
-34.61%48.28M
-50.19%43.79M
5.42%43.38M
122.90%59.41M
122.90%59.41M
136.85%73.83M
150.78%87.92M
14.86%41.15M
Free cash flow
-2,319.03%-60.38M
0.21%-16.96M
25.20%-14.28M
-123.57%-13.89M
39.72%-15.26M
97.27%-2.5M
26.87%-16.99M
16.89%-19.09M
380.74%58.9M
-4.22%-25.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2,608.07%-60.07M-0.22%-16.8M25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M
Net income from continuing operations -669.97%-74.88M-22.73%-20.33M9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M
Depreciation and amortization -12.74%1.39M-5.96%347K-6.23%346K-8.51%344K-26.30%353K-26.66%1.59M-27.36%369K-30.51%369K-33.69%376K-15.37%479K
Change In working capital 192.04%3.91M124.16%506K657.32%2.29M1,497.92%1.34M86.47%-223K7.91%-4.25M-103.10%-2.09M73.92%-410K-112.31%-96K40.93%-1.65M
-Change in receivables 234.45%2.1M--0--0141.96%979K108.01%1.12M-406.17%-1.56M3,527.91%1.56M-1,840.79%-1.32M-318.85%-2.33M313.08%537K
-Change in prepaid assets 219.56%1.63M121.26%44K101.82%44K-162.20%-288K128.14%1.83M-27.33%-1.37M66.72%-207K-250.29%-2.42M-39.40%463K253.83%803K
-Change in payables and accrued expense 155.35%1.45M135.54%1.19M52.25%2.43M-57.05%831K-6.24%-3M-56.44%-2.63M-3,727.17%-3.34M369.48%1.6M107.17%1.94M-33.63%-2.82M
-Change in other current assets -126.39%-528K-901.52%-529K-99.84%3K-100.00%-2K--02,028.72%2M414.29%66K38,160.00%1.91M-102.78%-1K-68.92%23K
-Change in other working capital -6.14%-743K-10.80%-195K-12.07%-195K-11.25%-178K7.89%-175K57.55%-700K66.35%-176K52.72%-174K59.70%-160K47.37%-190K
Cash from discontinued investing activities
Operating cash flow -2,608.07%-60.07M-0.22%-16.8M25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M
Investing cash flow
Cash flow from continuing investing activities -4.69%30.72M-146.42%-1.05M327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M
Net PPE purchase and sale -12.95%-314K31.17%-159K-373.68%-90K---65K--045.28%-278K-200.00%-231K70.77%-19K--083.63%-28K
Net investment purchase and sale -4.54%31.03M-135.73%-890K328.06%18.7M211.91%14M-102.04%-777K189.84%32.51M-86.48%2.49M-77.11%4.37M-162.32%-12.51M140.69%38.16M
Cash from discontinued investing activities
Investing cash flow -4.69%30.72M-146.42%-1.05M327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M
Financing cash flow
Cash flow from continuing financing activities 6,042.28%168.67M202,673.49%168.3M-89.92%64K-20.16%301K0-97.68%2.75M-71.08%83K635K165.49%377K-98.60%1.65M
Net common stock issuance --164.5M------------------0--0--0--0--0
Proceeds from stock option exercised by employees 51.75%4.17M4,480.72%3.8M-89.92%64K-20.16%301K--0253.41%2.75M-71.08%83K--635K165.49%377K374.43%1.65M
Cash from discontinued financing activities
Financing cash flow 6,042.28%168.67M202,673.49%168.3M-89.92%64K-20.16%301K--0-97.68%2.75M-71.08%83K--635K165.49%377K-98.60%1.65M
Net cash flow
Beginning cash position 122.90%59.41M-34.61%48.28M-50.19%43.79M5.42%43.38M122.90%59.41M-26.35%26.66M136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M
Current changes in cash 325.30%139.32M1,143.52%150.46M131.84%4.49M-99.11%414K-210.62%-16.03M443.56%32.76M-219.19%-14.42M-262.51%-14.09M6,189.58%46.77M4,082.14%14.5M
End cash Position 234.50%198.73M234.50%198.73M-34.61%48.28M-50.19%43.79M5.42%43.38M122.90%59.41M122.90%59.41M136.85%73.83M150.78%87.92M14.86%41.15M
Free cash flow -2,319.03%-60.38M0.21%-16.96M25.20%-14.28M-123.57%-13.89M39.72%-15.26M97.27%-2.5M26.87%-16.99M16.89%-19.09M380.74%58.9M-4.22%-25.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -